Literature DB >> 3277918

Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen.

R L Richards1, M D Hayre, W T Hockmeyer, C R Alving.   

Abstract

A liposome-encapsulated cloned protein (R32tet32) containing sequences from the tetrapeptide repeat region of the circumsporozoite protein of Plasmodium falciparum sporozoites was examined for immunogenicity with rabbits and monkeys. Effects of adjuvants were tested by encapsulation of the antigen in liposomes either lacking or containing lipid A and adsorption with aluminum hydroxide (ALUM). When rabbits were immunized with R32tet32 alone, a primary antibody response was not seen and a secondary response did not appear until 32 to 36 weeks after boosting. Immunization with ALUM-adsorbed R32tet32 resulted in a minimal primary antibody response. A moderate secondary antibody response was detected within 2 weeks after boosting, but antibody levels decreased to preimmunization levels 8 weeks after boosting. When R32tet32 was encapsulated in liposomes containing lipid A, strong primary and secondary antibody responses were observed. Strong primary and secondary responses also were obtained when R32tet32 was encapsulated in liposomes either containing or lacking lipid A and the liposomes were adsorbed with ALUM. The strongest antibody response was obtained by immunization with ALUM-adsorbed liposomes containing lipid A and R32tet32, suggesting that the adjuvant effects of liposomes, lipid A, and ALUM were additive or synergistic.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3277918      PMCID: PMC259345          DOI: 10.1128/iai.56.3.682-686.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes.

Authors:  P T Naylor; H S Larsen; L Huang; B T Rouse
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

Review 2.  Vaccine adjuvants.

Authors:  R Edelman
Journal:  Rev Infect Dis       Date:  1980 May-Jun

3.  Endotoxin enhanced adjuvant effect of liposomes, particularly when antigen and endotoxin are incorporated within the same liposome.

Authors:  N van Rooijen; R van Nieuwmegen
Journal:  Immunol Commun       Date:  1980

4.  Potentiation of the immune response to influenza virus subunit vaccines.

Authors:  R G Webster; W P Glezen; C Hannoun; W G Laver
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

5.  Interactions of lipid a and liposome-associated lipid A with Limulus polyphemus amoebocytes.

Authors:  E C Richardson; B Banerji; R C Seid; J Levin; C R Alving
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

6.  Humoral and cellular immunity to hepatitis B virus-derived antigens: comparative activity of Freund complete adjuvant alum, and liposomes.

Authors:  Y Sanchez; I Ionescu-Matiu; G R Dreesman; W Kramp; H R Six; F B Hollinger; J L Melnick
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

7.  Effects of lipid A and liposomes containing lipid A on platelet and fibrinogen production in rabbits.

Authors:  R B Ramsey; M B Hamner; B M Alving; J S Finlayson; C R Alving; B L Evatt
Journal:  Blood       Date:  1980-08       Impact factor: 22.113

8.  Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites.

Authors:  D A Herrington; D F Clyde; G Losonsky; M Cortesia; J R Murphy; J Davis; S Baqar; A M Felix; E P Heimer; D Gillessen
Journal:  Nature       Date:  1987 Jul 16-22       Impact factor: 49.962

9.  Sporozoites of mammalian malaria: attachment to, interiorization and fate within macrophages.

Authors:  H D Danforth; M Aikawa; A H Cochrane; R S Nussenzweig
Journal:  J Protozool       Date:  1980-05

10.  Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax.

Authors:  E H Nardin; V Nussenzweig; R S Nussenzweig; W E Collins; K T Harinasuta; P Tapchaisri; Y Chomcharn
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

View more
  17 in total

1.  Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages.

Authors:  J N Verma; M Rao; S Amselem; U Krzych; C R Alving; S J Green; N M Wassef
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 2.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

3.  Liposome-entrapped T-cell peptide provides help for a co-entrapped B-cell peptide to overcome genetic restriction in mice and induce immunological memory.

Authors:  G Gregoriadis; Z Wang; Y Barenholz; M J Francis
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

4.  Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy.

Authors:  L F Fries; D M Gordon; R L Richards; J E Egan; M R Hollingdale; M Gross; C Silverman; C R Alving
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

Review 5.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

6.  Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195.

Authors:  G S Hui; L Q Tam; S P Chang; S E Case; C Hashiro; W A Siddiqui; T Shiba; S Kusumoto; S Kotani
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

7.  Use of a tuberculin purified protein derivative--Asn-Ala-Asn-Pro conjugate in bacillus Calmette-Guérin primed mice overcomes H-2 restriction of the antibody response and avoids the need for adjuvants.

Authors:  A R Lussow; G Del Giudice; L Rénia; D Mazier; J P Verhave; A S Verdini; A Pessi; J A Louis; P H Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 8.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

9.  Resistance to acute Trypanosoma cruzi infection resulting from immunization of mice with a 90-kilodalton antigen from metacyclic trypomastigotes.

Authors:  J González; M F Araguth; N Yoshida
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

10.  Antibody responses in the serum and respiratory tract of mice following oral vaccination with liposomes coated with filamentous hemagglutinin and pertussis toxoid.

Authors:  C A Guzman; G Molinari; M W Fountain; M Rohde; K N Timmis; M J Walker
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.